05:19p | PRESIDIO PROPERTY TRUST, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) | AQ |
05:19p | ZYMEWORKS INC. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
05:19p | IOVANCE BIOTHERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
05:19p | Workday Stock Falls After Loss Doubles; Adjusted. EPS Falls Short | DJ |
05:18p | PDS BIOTECHNOLOGY CORP : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
05:18p | INTEGRAL AD SCIENCE HOLDING CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) | AQ |
05:18p | NORDIC AQUA PARTNERS A/S : Minutes from Annual General Meeting | AQ |
05:18p | VMWARE, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | AQ |
05:18p | BGL Announces the Sale of ROCA ACERO S.A. de C.V. | PR |
05:17p | DIODES INC /DEL/ : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
05:17p | Douglas Emmett Declares Quarterly Cash Dividend | BU |
05:16p | PHENIXFIN CORP : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
05:16p | CCC INTELLIGENT SOLUTIONS HOLDINGS INC. : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
05:16p | Venzee Technologies Updates Schedule Details for Webcast and First Quarter 2022 Financial Release | AQ |
05:16p | REINSURANCE GROUP OF AMERICA INC : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
05:16p | ZOVIO INC Financial Statements and Exhibits (form 8-K/A) | AQ |
05:16p | GOLDMAN SACHS BDC, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) | AQ |
05:16p | GXO LOGISTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
05:16p | ABCOURT ANNONCE Les Resultats Financiers Pour Le Trimestre Termine Le 31 Mars 2022 | AQ |
05:16p | eFFECTOR Therapeutics to Present Interim Data from Ongoing Zotatifin Phase 1/2 Dose Escalation and Expansion Trial at 2022 ASCO Annual Meeting | GL |
05:16p | HOOKIPA to Present Complete HB-200 Phase 1 Results and Recommended Phase 2 Dose for HB-202/HB-201 for the Treatment of Advanced HPV16+ Cancers at ASCO | GL |
05:16p | SpringWorks Therapeutics Highlights Nirogacestat Clinical Data at the 2022 ASCO Annual Meeting | GL |
05:15p | Oncternal Therapeutics Presents Updated Interim Data for Zilovertamab in Combination with Ibrutinib at ASCO 2022 | AQ |
05:15p | SpringWorks Therapeutics Highlights Nirogacestat Clinical Data at the 2022 ASCO Annual Meeting | AQ |
05:15p | HOOKIPA to Present Complete HB-200 Phase 1 Results and Recommended Phase 2 Dose for HB-202/HB-201 for the Treatment of Advanced HPV16+ Cancers at ASCO | AQ |
05:15p | EFFECTOR Therapeutics to Present Interim Data from Ongoing Zotatifin Phase 1/2 Dose Escalation and Expansion Trial at 2022 ASCO Annual Meeting | AQ |
05:15p | Replimune To Present at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting | AQ |
05:14p | HAMILTON LANE INC Management's Discussion and Analysis of Financial Condition and Results
of Operations (form 10-K) | AQ |
05:14p | RAPID MICRO BIOSYSTEMS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
05:14p | MIRATI THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
05:14p | QUAD/GRAPHICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
05:14p | CHEMBIO DIAGNOSTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
05:14p | ADICET BIO, INC. : Regulation FD Disclosure, Other Events (form 8-K) | AQ |
05:13p | ABCOURT Report is Financial Results for the Quarter Ended March 31, 2022 | AQ |
05:13p | RED ROBIN GOURMET BURGERS INC Management's Discussion and Analysis of Financial Condition and Results
of Operations (form 10-Q) | AQ |
05:12p | Spain's CNMV authorizes MFE bid for rest of Mediaset Espana | RE |
05:12p | Pemex crude exports rise 13% m/m in April, production dips | RE |
05:12p | PROTALIX BIOTHERAPEUTICS, INC. : Regulation FD Disclosure (form 8-K) | AQ |
05:12p | TEMPEST THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
05:12p | ARBUTUS BIOPHARMA CORP : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
05:12p | Protara Therapeutics Announces Trials in Progress Poster Presentation for the ADVANCED-1 Trial in NMIBC at the 2022 American Society of Clinical Oncology Annual Meeting | AQ |
05:12p | Aravive Presents Updated Clinical Data at ASCO Showing Continued Best-in-Class Potential of Batiraxcept in Advanced or Metastatic clear cell Renal Cell Carcinoma (ccRCC) | AQ |
05:11p | FANHUA : Q1 Earnings Snapshot | AQ |
05:11p | AVIS BUDGET GROUP, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
05:11p | New Data to be Shared at ASCO 2022 Underscore Clinical Utility of Decipher Prostate Genomic Classifier | BU |